tiprankstipranks

New Portfolio - New Portfolio

Jason Moore

New Portfolio
Individual Investor
Ranked #229,353 out of 769,002 TipRanks' Investors
Success Rate
39%
40 out of 104
profitable transactions
Average Return
36.46%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 0.39%
6-Month Return▲ 3.15%
12-Month Return-
YTD Return▼ 10.80%
Total Return▼ 10.80%

Best Trade

Opened at
Closed at-
Gain▲ 2972.11%

Bio

Performance

25.72%0-25.72%
▼ 12.40%
▼ 4.03%
▼ 13.38%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 2.86%
May 2024
▼ 2.25%
▲ 3.53%
▼ 4.22%
Jun 2024
▲ 25.72%
▲ 1.21%
▲ 10.90%
Jul 2024
▼ 4.22%
▲ 2.34%
▼ 6.15%
Aug 2024
▲ 7.82%
▲ 2.10%
▼ 1.00%
Sep 2024
▲ 5.70%
▼ 0.89%
▲ 3.08%
Oct 2024
▲ 23.63%
▲ 3.84%
▲ 3.99%
Nov 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 12.40%▼ 4.03%▼ 13.38%
▲ 11.46%▲ 5.06%▲ 2.86%
▼ 2.25%▲ 3.53%▼ 4.22%
▲ 25.72%▲ 1.21%▲ 10.90%
▼ 4.22%▲ 2.34%▼ 6.15%
▲ 7.82%▲ 2.10%▼ 1.00%
▲ 5.70%▼ 0.89%▲ 3.08%
▲ 23.63%▲ 3.84%▲ 3.99%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Petiq
▲ 69.01%
2
Close
Oct 24, 2024
Terran Orbital Corp
▼ 70.78%
2
Close
Aug 21, 2024
Avidity Biosciences
0.99%
▲ 103.40%
1
Open
Mar 08, 2024
Opus Genetics
0.99%
▼ 50.75%
1
Open
Mar 08, 2024
NRX Pharmaceuticals
0.99%
▼ 80.27%
1
Open
Mar 08, 2024
Abeona Therapeutics
0.99%
▼ 27.85%
1
Open
Mar 08, 2024
Cardio Diagnostics Holdings
0.99%
▼ 82.19%
1
Open
Mar 08, 2024
Infobird Co
0.99%
▼ 72.99%
1
Open
Mar 08, 2024
Ocean Biomedical
0.99%
▼ 87.59%
1
Open
Mar 08, 2024
Akebia Therapeutics
0.99%
▲ 21.77%
1
Open
Mar 08, 2024
Agenus
0.99%
▼ 80.08%
1
Open
Mar 08, 2024
Legend Biotech
0.99%
▼ 36.54%
1
Open
Mar 08, 2024
Theratechnologies
0.99%
▲ 0.83%
1
Open
Mar 08, 2024
BeiGene
0.99%
▲ 22.55%
1
Open
Mar 08, 2024
Optinose
0.99%
▼ 78.15%
1
Open
Mar 08, 2024
Supernus Pharmaceuticals
0.99%
▲ 16.25%
1
Open
Mar 08, 2024
Cardiff Oncology
0.99%
▼ 38.89%
1
Open
Mar 08, 2024
Vanda
0.99%
▲ 26.62%
1
Open
Mar 08, 2024
Geron
0.99%
▲ 77.33%
1
Open
Mar 08, 2024
Liquidia Technologies
0.99%
▼ 27.92%
1
Open
Mar 08, 2024